SCHEMBL9150323

SCHEMBL9150323

CCCCCCCCCCCCCCn1ccc(C(=O)O)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.56
PLA2G4A P47712 1/20 0.53
NPC1 O15118 6/20 0.49
RAB9A P51151 6/20 0.49
HTT P42858 5/20 0.49
LMNA P02545 3/20 0.49
GALR3 O60755 2/20 0.49
POLB P06746 2/20 0.49
ATM Q13315 2/20 0.49
MAPK1 P28482 2/20 0.49
NPSR1 Q6W5P4 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
APOBEC3A P31941 2/20 0.49
APOBEC3G Q9HC16 2/20 0.49
MAPT P10636 2/20 0.49
KDM4E B2RXH2 1/20 0.49
HSP90AA1 P07900 1/20 0.49
RAD52 P43351 1/20 0.49
PAX8 Q06710 1/20 0.49
NR2F2 P24468 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22291138 1.00 CNR1 (0.56) CNR1PLA2G4ANPC1RAB9AHTT
SCHEMBL21413172 1.00 CNR1 (0.56) CNR1PLA2G4ANPC1RAB9AHTT
SCHEMBL22748618 0.88 PLA2G4A (0.50) CNR1PLA2G4ATP53TSHRRARB
SCHEMBL7755595 0.86 KDM5A (0.48) CNR1PLA2G4APOLBKDM4EALDH1A1
SCHEMBL28669934 0.85 CNR1 (0.54) CNR1PLA2G4ANPC1RAB9AHTT
SCHEMBL29038550 0.85 CNR1 (0.54) CNR1PLA2G4ANPC1RAB9AHTT
SCHEMBL29038572 0.85 CNR1 (0.54) CNR1PLA2G4ANPC1RAB9AHTT
SCHEMBL27945337 0.85 CNR1 (0.54) CNR1PLA2G4ANPC1RAB9AHTT
SCHEMBL22749024 0.85 PLA2G4A (0.47) CNR1PLA2G4APOLBMAPTALDH1A1
SCHEMBL22748665 0.85 PLA2G4A (0.50) CNR1PLA2G4ATP53TSHRRARB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE35096-E Antilipemic, anticholesterol, arteriosclerosis MITSUBISHI CHEMICAL CORPORATION (JP) 1995-11-21 US disclosed
US-5082856-A Hyperlipemia, arteriosclerosis MITSUBISHI KASEI CORPORATION (JP) 1992-01-21 US disclosed
EP-0347902-A2 Pyrrolecarboxylic acid derivatives Mitsubishi Chemical Corporation (JP) 1989-12-27 EP disclosed